Global Lung Cancer Diagnostic And Screening Market Growth (Status and Outlook) 2025-2031

Report ID: 3028445 | Published Date: Jan 2026 | No. of Page: 137 | Base Year: 2025 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025

The global Lung Cancer Diagnostic And Screening market size is predicted to grow from US$ 85.2 million in 2025 to US$ 113 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

The Lung Cancer Diagnostic and Screening market is experiencing significant growth and is expected to continue to expand in the coming years. Lung cancer is a major global health concern, and early detection and accurate diagnosis are crucial for improving patient outcomes.

One major trend in the Lung Cancer Diagnostic and Screening market is the increasing adoption of advanced imaging technologies for lung cancer detection. Technologies such as computed tomography (CT) scans and positron emission tomography (PET) scans are widely used for screening and diagnosing lung cancer. These imaging techniques provide detailed images of the lungs, allowing healthcare professionals to detect lung nodules or tumors at an early stage.

Segmentation by Type:

  • Instrument
  • Consumables and Accessories

Segmentation by Application:

  • Hospital
  • Independent Diagnostic Laboratory

Market by Region:

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company's Coverage:

  • Pfizer
  • F.Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • Thermo Fisher Scientific
  • AstraZeneca Plc
  • Abbott Laboratories
  • Medtronic Plc
  • Danaher Corporation
  • Siemens Healthcare GmbH
  • FUJIFILM Corporation
  • KoninklijikePhilips N.V.
  • GE Healthcare Bio Sciences AB
  • Quest Diagnostics Incorporated
  • Agilent Technologies Inc
  • Qiagen Inc.
  • Myriad Genetic Laboratories Inc.
  • NeoGenomics Laboratories Inc
  • Canon Medical Systems Corporation
  • Eon Health Inc

Key Questions Addressed in this Report:

  • What are the key trends shaping the market?
  • What are the growth opportunities in the market?
  • Who are the key players in the market?
Frequently Asked Questions
Lung Cancer Diagnostic And Screening report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lung Cancer Diagnostic And Screening report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lung Cancer Diagnostic And Screening report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports